Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

3.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.5K
Vaccinations01:51

Vaccinations

52.0K
Overview
52.0K
Development of Immunocompetence01:22

Development of Immunocompetence

1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons.

Epidemiology and infection·2012
Same author

Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Nosocomial measles cluster in Denmark following an imported case, December 2008-January 2009.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2009
Same author

Measles is still a cause for concern in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
Same author

A cluster of measles cases in Denmark following importation, January and February 2008.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
Same journal

Author's correction for Euro Surveill. 2026;31(24).

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Dermatophilosis among men who have sex with men, Stockholm, Sweden, March to June, 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Ongoing multi-country outbreak of carbapenem-resistant <i>Enterobacter hormaechei</i> ST1344 carrying <i>bla</i> <sub>NDM-5</sub> in the European Union/European Economic Area, March 2025 to April 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
See all related articles

Related Experiment Video

Updated: Feb 18, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K

Rubella in Denmark.

S Glismann1

  • 1Statens Serum Institut, Copenhagen, Denmark.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|November 30, 2017
PubMed
Summary
This summary is machine-generated.

Denmark

Keywords:
rubellavaccines and immunisation

More Related Videos

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.5K
Pan-lyssavirus Real Time RT-PCR for Rabies Diagnosis
06:25

Pan-lyssavirus Real Time RT-PCR for Rabies Diagnosis

Published on: July 10, 2019

22.6K

Related Experiment Videos

Last Updated: Feb 18, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.5K
Pan-lyssavirus Real Time RT-PCR for Rabies Diagnosis
06:25

Pan-lyssavirus Real Time RT-PCR for Rabies Diagnosis

Published on: July 10, 2019

22.6K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Vaccinology

Background:

  • Rubella (German measles) incidence in Denmark averaged 20,000 cases annually until 1987.
  • A significant decline to 1006 cases in 1989 indicated successful public health interventions.
  • Current rubella incidence is considered very low, below 1 per 100,000 population.

Purpose of the Study:

  • To assess the impact of vaccination strategies on rubella incidence in Denmark.
  • To evaluate the sustainability of low rubella rates.
  • To consider future steps for rubella control aligned with WHO goals.

Main Methods:

  • Analysis of historical rubella case data in Denmark.
  • Review of vaccination program implementation dates and policies.
  • Examination of notifiable disease status changes for rubella-related conditions.

Main Results:

  • Rubella incidence dramatically decreased following the initiation of rubella vaccination for women of childbearing age in 1980.
  • Further reductions were observed with the refunding of childhood vaccinations in 1982 and the introduction of the Measles, Mumps, and Rubella (MMR) vaccine in 1987.
  • Congenital rubella syndrome and rubella in pregnancy became notifiable diseases in 1994, contributing to sustained low incidence.

Conclusions:

  • Vaccination programs, particularly targeting women and children, have been highly effective in reducing rubella incidence in Denmark.
  • The current low incidence is sustainable through ongoing vaccination efforts and disease surveillance.
  • Mandatory reporting of laboratory-diagnosed rubella cases is being considered to meet World Health Organization (WHO) rubella control objectives.